Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir boosted atazanavir nanoformulations

Long-acting nanoformulated antiretroviral therapy (nanoART) that target monocyte-macrophage could improve the drug’s half-life and protein binding capacities while facilitating cell and tissue depots. To this end, ART nanoparticles that target the folic acid (FA) receptor and permit cell-based drug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biomaterials
Autores principales: Puligujja, Pavan, Balkundi, Shantanu, Kendrick, Lindsey, Baldridge, Hannah, Hilaire, James, Bade, Aditya N., Dash, Prasanta K., Zhang, Gang, Poluektova, Larisa, Gorantla, Santhi, Liu, Xin-Ming, Ying, Tianlei, Feng, Yang, Wang, Yanping, Dimitrov, Dimiter S., McMillan, JoEllyn M., Gendelman, Howard E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272445/
https://ncbi.nlm.nih.gov/pubmed/25522973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2014.11.012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares